Jerry Bohlen

University of Maryland, Baltimore

Papers

1

Total Citations

1

H-Index

1

About

Dr. Jerry Bohlen is a leading voice in transplant hepatology, with a focused expertise on the intersection of metabolic disease and liver transplantation. His work addresses the critical challenge of optimizing outcomes for morbidly obese cirrhotic patients, a population that has grown dramatically as metabolic dysfunction-associated steatohepatitis (MASH) becomes a primary driver of end-stage liver disease. In his highly cited narrative review, Dr. Bohlen systematically outlines the perioperative risks and surgical strategies for this complex cohort, offering a practical framework for managing elevated BMI in transplant candidates. His contributions are shaping clinical protocols for patient selection and postoperative care, directly impacting survival rates in a high-risk group. With a citation count reflecting the urgent relevance of his research, Dr. Bohlen is recognized for bridging the gap between bariatric principles and transplant medicine. His work not only highlights the rising burden of obesity in hepatology but also provides actionable solutions for improving graft and patient outcomes in an era of evolving donor and recipient demographics.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Challenges and strategies for optimizing liver transplantation outcomes in morbidly obese cirrhotic patients: a narrative review
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: University of Maryland, Baltimore

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago